FDA moves toward easing restrictions on certain peptides BioPharma Dive The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York of the Federal Food, Drug, and Cosmetic Act (FDCA).* BPC 157 Review: Doctor Explains Benefits, Safety & Cancer Risk FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures wkyc.com